These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 4846281)

  • 21. Understanding iron absorption and metabolism, aided by studies of hemochromatosis.
    Roeckel IE; Dickson LG
    Ann Clin Lab Sci; 1998; 28(1):30-3. PubMed ID: 9512782
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The determination of iron absorption and iron retention with a total body counter especially, in patient with idiopathic hemochromatosis].
    Flendrig JA; van Tongeren JH; Hogeweg B; Verhoef CW
    Ned Tijdschr Geneeskd; 1968 May; 112(19):923-4. PubMed ID: 5668478
    [No Abstract]   [Full Text] [Related]  

  • 23. Hepatic and serum ferritin concentrations in patients with idiopathic hemochromatosis.
    Beaumont C; Simon M; Smith PM; Worwood M
    Gastroenterology; 1980 Nov; 79(5 Pt 1):877-83. PubMed ID: 7419012
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Study of iron exchange hemochromatosis, with particular regard to blood iron levels].
    NAPOLITANO L; SCURO LA
    Prog Med (Napoli); 1954 Nov; 10(22):676-88. PubMed ID: 13237356
    [No Abstract]   [Full Text] [Related]  

  • 25. [Hemochromatosis].
    Simon M; Hespel JP; Brissot P; Fauchet R; Edan G; Le Reun M; Le Mignon L; Genetet B; Bourel M
    Ann Med Interne (Paris); 1981; 132(6):413-33. PubMed ID: 7032384
    [No Abstract]   [Full Text] [Related]  

  • 26. [Recent results of iron metabolism in hemochromatosis].
    HEILMEYER L
    Dtsch Med Wochenschr; 1954 Feb; 79(8):280-4. PubMed ID: 13150860
    [No Abstract]   [Full Text] [Related]  

  • 27. [Iron metabolism in hemochromatosis].
    REMY D
    Dtsch Med Wochenschr; 1954 Jun; 79(26):1042-4. PubMed ID: 13182898
    [No Abstract]   [Full Text] [Related]  

  • 28. Proceedings of the 4th International Conference on Hemochromatosis and Clinical Problems in Iron Metabolism, and the 11th International Conference on Iron and Iron Proteins. Jerusalem, Israel, April 27-30, 1993 and May 2-7, 1993.
    Adv Exp Med Biol; 1994; 356():1-402. PubMed ID: 7887214
    [No Abstract]   [Full Text] [Related]  

  • 29. Gastric iron binding in haemochromatosis.
    Smith PM
    Lancet; 1968 Nov; 2(7578):1143. PubMed ID: 4177190
    [No Abstract]   [Full Text] [Related]  

  • 30. Gastric iron-binding in haemochromatosis.
    Luke CG; Davis PS; Deller DJ
    Lancet; 1968 Dec; 2(7583):1392. PubMed ID: 4177948
    [No Abstract]   [Full Text] [Related]  

  • 31. Does free extracellular iron exist in haemochromatosis and other pathologies, and is it redox active?
    Richardson DR; Dean RT
    Clin Sci (Lond); 2001 Mar; 100(3):237-8. PubMed ID: 11222108
    [No Abstract]   [Full Text] [Related]  

  • 32. Reduction of gastric iron-binding protein in haemochromatosis. A previously unrecognised metabolic defect.
    Davis PS; Luke CG; Deller DJ
    Lancet; 1966 Dec; 2(7479):1431-3. PubMed ID: 4163439
    [No Abstract]   [Full Text] [Related]  

  • 33. Iron-binding properties of gastric juice in idiopathic haemochromatosis.
    Wynter CV; Williams R
    Lancet; 1968 Sep; 2(7567):534-7. PubMed ID: 4175398
    [No Abstract]   [Full Text] [Related]  

  • 34. Site of principal metabolic defect in idiopathic haemochromatosis: insights from transplantation of an affected organ.
    Dabkowski PL; Angus PW; Smallwood RA; Ireton J; Jones RM
    BMJ; 1993 Jun; 306(6894):1726. PubMed ID: 8343629
    [No Abstract]   [Full Text] [Related]  

  • 35. Can iron fortification of flour cause damage to genetic susceptibles (idiopathic haemochromatosis and beta-thalassaemia major)?
    Bothwell TH; Derman D; Bezwoda WR; Torrance JD; Charlton RW
    Hum Genet Suppl; 1978; (1):131-7. PubMed ID: 285024
    [No Abstract]   [Full Text] [Related]  

  • 36. Beeturia and iron absorption.
    Sotos JG
    Lancet; 1999 Sep; 354(9183):1032. PubMed ID: 10501390
    [No Abstract]   [Full Text] [Related]  

  • 37. Clinical trial of 5-hydroxypicolinaldehyde thiosemicarbazone (5-HP; NSC-107392), with special reference to its iron-chelating properties.
    Krakoff IH; Etcubanas E; Tan C; Mayer K; Bethune V; Burchenal JH
    Cancer Chemother Rep; 1974; 58(2):207-12. PubMed ID: 4598241
    [No Abstract]   [Full Text] [Related]  

  • 38. Iron metabolism and the liver with particular reference to the pathogenesis of haemochromatosis.
    WILLIAMS R; PITCHER CS
    Postgrad Med J; 1963 Apr; 39(450):193-204. PubMed ID: 14000916
    [No Abstract]   [Full Text] [Related]  

  • 39. WINE AS SOURCE OF IRON IN HAEMOCHROMATOSIS.
    MACDONALD RA
    Nature; 1963 Aug; 199():922. PubMed ID: 14079915
    [No Abstract]   [Full Text] [Related]  

  • 40. DIABETIC RETINOPATHY AND HAEMOCHROMATOSIS.
    GALTON DJ
    Br Med J; 1965 May; 1(5443):1169. PubMed ID: 14273525
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.